MXC.AX - MGC Pharmaceuticals Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures4

Market cap (intra-day) 28.66M
Enterprise value 29.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.52
Price/book (mrq)N/A
Enterprise value/revenue 6.21
Enterprise value/EBITDA -1.26

Trading information

Stock price history

Beta (5Y monthly) 1.20
52-week change 3-65.85%
S&P500 52-week change 31.77%
52-week high 30.0240
52-week low 30.0060
50-day moving average 30.0086
200-day moving average 30.0119

Share statistics

Avg vol (3-month) 32.79M
Avg vol (10-day) 32.31M
Shares outstanding 53.35B
Implied shares outstanding 6N/A
Float 82.54B
% held by insiders 111.82%
% held by institutions 111.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 321 Aug 2012

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)31 Dec 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-342.52%

Management effectiveness

Return on assets (ttm)-45.50%
Return on equity (ttm)-307.40%

Income statement

Revenue (ttm)4.81M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)3.10%
Gross profit (ttm)562.87k
EBITDA -16.39M
Net income avi to common (ttm)-23.34M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.13M
Total cash per share (mrq)0
Total debt (mrq)10.03M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.39
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-13.52M
Levered free cash flow (ttm)-8.99M